首页> 外文期刊>Journal of Drug Delivery and Therapeutics >EVALUATION OF COMPRESSION PROCESS VARIABLES FOR MULTIUNIT PARTICULATE SYSTEM (MUPS) TABLET BY QBD APPROACH
【24h】

EVALUATION OF COMPRESSION PROCESS VARIABLES FOR MULTIUNIT PARTICULATE SYSTEM (MUPS) TABLET BY QBD APPROACH

机译:用QBD方法评价多单位微粒系统(MUPS)平板的压缩过程变量。

获取原文
           

摘要

Objective: The objective of the study was to evaluate and optimize compression process variables of Esomeprazole (Multiunit particulate system) MUPS tablet. Materials and methods: A three-factor, two-level, full factorial design was used to investigate the influence process variables Viz. Main compression force, Pre-compression force and Turret speed. Responses studied were Weight variation, Hardness, Thickness, Friability, Content uniformity, Drug release in 0.1N HCl at 120min and drug release in pH 6.5 simulated intestinal fluid at 15 min. Results and discussion: Main compression force and the Pre-compression force had a significant influence on hardness, thickness, drug release in 0.1N HCl at 120min and drug release in pH 6.5 SIF at 15min. Higher compression force leads to breakage of pellets during compression which showed impact drug release at acid stage. Turret speed had significant impact on final weight variation and content uniformity. The optimized process parameters Main compression force: 11.33 kP, Pre-compression force: 2.72 Kp and Turret speed: 23.56 rpm showed desired physical characteristics and drug release in 0.1N HCl which will result in lesser degradation of API at acid stage. Conclusion: It is concluded that Compression process variables in preparation of Esomeprazole MUPS were successfully evaluated using Design of Experiment approach.
机译:目的:本研究的目的是评估和优化埃索美拉唑(多单位颗粒系统)MUPS片剂的压制过程变量。材料和方法:采用三因子,两级,全因子设计来研究影响过程变量Viz。主压缩力,预压缩力和转塔速度。研究的反应是重量变化,硬度,厚度,脆性,含量均匀性,120分钟在0.1N HCl中的药物释放和15分钟在pH 6.5模拟肠液中的药物释放。结果与讨论:主压缩力和预压缩力对硬度,厚度,120分钟在0.1N HCl中的药物释放以及15分钟在pH 6.5 SIF中的药物释放具有显着影响。较高的压缩力会导致压缩过程中药丸破裂,这表明药物在酸性阶段会释放出来。转塔速度对最终重量变化和含量均匀度有重要影响。优化的工艺参数主要压缩力:11.33 kP,预压缩力:2.72 Kp,转塔速度:23.56 rpm,显示出所需的物理特性和药物在0.1N HCl中的释放,这将减少酸阶段API的降解。结论:结论:使用实验设计方法成功评估了埃索美拉唑MUPS制备过程中的压缩过程变量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号